Brief: Palatin Completes Sale Of Vyleesi® To Cosette Pharmaceuticals For Up To $171 Million
20/12/2023 12:36
Dec 20 (Reuters) - Palatin Technologies Inc PTN.A :
* PALATIN COMPLETES SALE OF VYLEESI® TO COSETTE
PHARMACEUTICALS
FOR UP TO $171 MILLION
* PALATIN TECHNOLOGIES INC: PALATIN TO RECEIVE $12 MILLION
UPFRONT, PLUS SALES-BASED MILESTONES OF UP TO $159 MILLION
Source text for Eikon: ID:nPn5BB2mma
Further company coverage: PTN.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Palatin Technologies
See all newsPalatin Technologies Inc reports results for the quarter ended March 31 - Earnings Summary
Palatin Technologies Inc expected to post a loss of $1.20 a share - Earnings Preview
Palatin Technologies Q2 revenue rises yr/yr, net loss widens
Brief: Palatin Announces 1-For-50 Reverse Stock Split
Brief: Palatin Announces Positive Preclinical Efficacy Data For Oral MC4R Agonist PL7737 In Animal Model Of Obesity